Generated August 14, 2026 at 8:31 PM ET
· Covers August 14 trading day
· 10 of 261 ready 8-Ks selected
· AI-assisted overview
Today's filings featured significant M&A activity, including SpaceX's $60B all-stock acquisition of Anysphere (Cursor) and Proficient Auto Logistics' ~$130M acquisition of Hansen & Adkins funded with convertible notes. Centerspace completed a $318.8M sale of 14 apartment communities. Regulatory issues were prominent: Adagio Medical, Worksport, and Teads received Nasdaq deficiency or delisting notices. Leadership changes included a mass resignation at Smart Powerr and a new CEO at Neumora. Cycurion reported a Q2 earnings beat and a large contract, while HCW Biologics announced non-reliance on its Q1 financials.
leadership
negative
materiality 0.85
August 14, 2026, 4:00 PM ET
Smart Powerr Corp. loses CFO, secretary, and three board members in mass resignation
- CFO Yongjiang (Jackie) Shi resigned Aug 13, 2026; no reason given.
- Board members Zhongli Liu, Xiaoping Guo, Lulu Sun resigned same day; they chaired audit, compensation, and nominating committees.
- Executive director and Chief Sales Officer Yan Zhan resigned; Secretary Binfeng (Adeline) Gu also resigned.
ADGM
Adagio Medical Holdings, Inc.
regulatory
negative
materiality 0.80
August 14, 2026, 4:31 PM ET
Adagio Medical receives Nasdaq deficiency notice for equity shortfall
- Stockholders' equity was -$415,000 as of June 30, 2026, below Nasdaq's $2.5M minimum.
- Company has until Sept 28, 2026 to submit a compliance plan to regain compliance.
- If plan accepted, Nasdaq may grant 180-day extension; otherwise appeal to Hearings Panel.
SPCX
SPACE EXPLORATION TECHNOLOGIES CORP
M&A
positive
materiality 1.00
August 14, 2026, 8:23 AM ET
SpaceX completes $60B all-stock acquisition of Anysphere (Cursor)
- Merger effective Aug 14, 2026; Cursor becomes wholly owned subsidiary of SpaceX.
- Consideration: 389,289,254 Class A shares for Cursor common/preferred, based on $60.0B implied equity value.
- Vested Cursor RSUs converted to 1,752,426 shares; unvested RSUs/options assumed as ~29.1M RSUs and ~44.4M options.
PAL
Proficient Auto Logistics, Inc
M&A
positive
materiality 0.90
August 14, 2026, 8:45 AM ET
PAL closes H&A acquisition for ~$130M, funds with $75M 5.5% convertible notes due 2033
- Acquired Hansen & Adkins for ~$130M upfront: ~$75M assumed debt, ~$52M cash, 421,354 PAL shares to Steve Hansen; earnout up to ~$22.1M.
- Issued $75M 5.5% convertible senior notes due 2033; conversion price ~$6.50 (27.5% premium to $5.10 close); net proceeds ~$71.4M.
- Capped call transactions cost ~$9.2M, cap price $8.93/share, to reduce conversion dilution.
M&A
positive
materiality 0.80
August 14, 2026, 4:15 PM ET
Centerspace completes sale of 14 apartment communities for $318.8M; plans special distribution
- Completed sale of 14 multifamily communities across Denver, Minneapolis, Rapid City, and Bismarck for aggregate gross proceeds of $318.8M.
- Net proceeds used to repay $176M revolving credit facility; potential special distribution of $50-60M to shareholders and OP unitholders.
- Pro forma 2025 net income available to common shareholders rises to $28.3M from $17.1M; 2026 six-month net loss narrows to $7.8M from $13.9M.
regulatory
negative
materiality 0.75
August 14, 2026, 5:00 PM ET
Worksport receives Nasdaq delisting notice for bid price below $1.00
- On Aug 13, 2026, Nasdaq notified Worksport that bid price was below $1.00 for 30 consecutive business days (Jul 1-Aug 12, 2026).
- Company has 180 days, until Feb 9, 2027, to regain compliance; needs $1.00 closing bid for 10 consecutive business days.
- May be eligible for an additional 180-day cure period if it meets other Nasdaq Capital Market listing standards.
regulatory
negative
materiality 0.75
August 14, 2026, 4:41 PM ET
Teads receives Nasdaq delisting notice for bid price below $1.00
- Nasdaq notified Teads on Aug 11, 2026 that common stock bid price below $1.00 for 30 consecutive business days.
- Company has 180 days, until Feb 8, 2027, to regain compliance by closing at $1.00+ for 10 straight days.
- Teads may consider reverse stock split (within previously approved range) to cure deficiency.
earnings
positive
materiality 0.85
August 14, 2026, 8:39 AM ET
Cycurion beats Q2 consensus; gross margin up ~5x; lands $54.6M contract
- Q2 revenue $3.8M vs $3.62M consensus; EPS -$0.41 vs -$0.56; net loss -$4.0M improved from -$5.3M.
- Gross margin 29.1% vs 6.1% YoY; adjusted EBITDA -$1.4M vs -$2.1M; net debt down 28% to $5.8M.
- Secured $54.6M, 10-year contract with global consulting firm for state HHS system; >$5M annual recurring revenue starting Nov 2026.
NMRA
Neumora Therapeutics, Inc.
leadership
positive
materiality 0.75
August 14, 2026, 7:13 AM ET
Neumora appoints Joshua Pinto as CEO, narrows Q2 net loss to $43.1M
- Joshua Pinto named CEO and Board member; Paul Berns becomes Executive Chair, effective Aug 14, 2026.
- Doron Sagman, M.D., appointed Chief Medical Officer; brings 20+ years of clinical development experience.
- Q2 2026 net loss $43.1M vs $52.7M in Q2 2025; R&D $29.3M, G&A $12.9M; cash $116.8M as of June 30, 2026.
other material
negative
materiality 0.85
August 14, 2026, 3:00 PM ET
HCW Biologics non-reliance on Q1 2026 financials; EPS overstated by $0.80
- Audit Committee concluded Aug 10, 2026 that Q1 2026 financials in Form 10-Q (filed May 14, 2026) should no longer be relied upon.
- EPS overstated by $0.80: reported $2.19 basic/diluted; correct two-class allocation is 63.3% to common, 36.7% to participating securities.
- As of Mar 31, 2026: 904,312 weighted-average common shares; 524,501 shares from participating warrants outstanding.